Anthony J. Muslin
Affiliations: | Washington University, Saint Louis, St. Louis, MO |
Area:
Cell Biology, Molecular BiologyGoogle:
"Anthony Muslin"Parents
Sign in to add mentorBradford C. Berk | post-doc | 1986-1987 | Harvard Medical School - BWH |
Lewis T. Williams | post-doc | 1989-1994 | UCSF School of Medicine (Neurotree) |
Children
Sign in to add traineechunlai wu | grad student | Washington University (Neurotree) | |
Heming Xing | grad student | 2000 | Washington University |
Tanawat Jirakulaporn | grad student | 2004 | Washington University |
Brian J. DeBosch | grad student | 2008 | Washington University |
Jeffrey M. Lau | grad student | 2008 | Washington University |
Brandon M. Proctor | grad student | 2008 | Washington University |
Collaborators
Sign in to add collaboratorKendall J. Blumer | collaborator | Washington University School of Medicine (Neurotree) | |
Andrey S. Shaw | collaborator | 1994-1996 | Washington University School Medicine (Neurotree) |
Kerry Kornfeld | collaborator | 1995-1998 | Washington University School of Medicine |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Bergougnan L, Andersen G, Plum-Mörschel L, et al. (2020) Endothelial-protective effects of a G-protein-biased S1P agonist, SAR247799, in type-2 diabetes rats and a randomized placebo-controlled patient trial. British Journal of Clinical Pharmacology |
Bergougnan L, Armani S, Golor G, et al. (2020) First-in-human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple oral doses of SAR247799, a selective G-protein-biased Sphingosine-1 phosphate receptor-1 agonist for endothelial protection. British Journal of Clinical Pharmacology |
Poirier B, Briand V, Kadereit D, et al. (2020) A G protein-biased S1P agonist, SAR247799, protects endothelial cells without affecting lymphocyte numbers. Science Signaling. 13 |
Beauverger P, Ozoux ML, Bégis G, et al. (2019) Reversion of cardiac dysfunction by a novel orally available calcium/calmodulin-dependent protein kinase II inhibitor, RA306, in a genetic model of dilated cardiomyopathy. Cardiovascular Research |
Villard EF, Thedrez A, Blankenstein J, et al. (2016) PCSK9 Modulates the Secretion But Not the Cellular Uptake of Lipoprotein(a) Ex Vivo: An Effect Blunted by Alirocumab. Jacc. Basic to Translational Science. 1: 419-427 |
Pang P, Jin X, Proctor BM, et al. (2015) RGS4 inhibits angiotensin II signaling and macrophage localization during renal reperfusion injury independent of vasospasm. Kidney International. 87: 771-83 |
Williams JW, Yau D, Sethakorn N, et al. (2013) RGS3 controls T lymphocyte migration in a model of Th2-mediated airway inflammation. American Journal of Physiology. Lung Cellular and Molecular Physiology. 305: L693-701 |
Beharier O, Dror S, Levy S, et al. (2012) ZnT-1 protects HL-1 cells from simulated ischemia-reperfusion through activation of Ras-ERK signaling. Journal of Molecular Medicine (Berlin, Germany). 90: 127-38 |
Sari FR, Widyantoro B, Thandavarayan RA, et al. (2011) Attenuation of CHOP-mediated myocardial apoptosis in pressure-overloaded dominant negative p38α mitogen-activated protein kinase mice. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 27: 487-96 |
Siedlecki AM, Jin X, Thomas W, et al. (2011) RGS4, a GTPase activator, improves renal function in ischemia-reperfusion injury. Kidney International. 80: 263-71 |